MOLECULAR PHARMACEUTICS
Scope & Guideline
Pioneering Research in Drug Development and Molecular Medicine
Introduction
Aims and Scopes
- Drug Delivery Systems:
The journal publishes research on innovative drug delivery systems, including nanoparticles, liposomes, and micelles, that enhance the solubility, stability, and bioavailability of therapeutic agents. - Pharmacokinetics and Drug Metabolism:
Research articles explore the pharmacokinetic profiles of drugs, including absorption, distribution, metabolism, and excretion, often utilizing advanced modeling techniques. - Nanomedicine:
Molecular Pharmaceutics emphasizes the application of nanotechnology in pharmaceuticals, including the design and characterization of nanocarriers for targeted drug delivery. - Biopharmaceutical Development:
The journal covers the development of biopharmaceuticals, including monoclonal antibodies and gene therapies, focusing on formulation challenges and in vivo performance. - Theranostics:
Research on theranostic approaches, which combine therapeutic and diagnostic capabilities, is a key area of interest, particularly in cancer treatment. - Drug Formulation and Stability:
Studies related to the formulation of drugs, including solid dispersions and stability assessments under various conditions, are central to the journal's scope. - Molecular Interactions and Physicochemical Properties:
The journal investigates the molecular interactions between drugs and excipients, exploring how these interactions affect drug performance and formulation stability.
Trending and Emerging
- mRNA and Gene Delivery Technologies:
There is a significant increase in research related to mRNA-based therapies and gene delivery systems, especially in the context of vaccines and cancer treatments. - Nanotechnology in Drug Delivery:
The use of nanotechnology for drug delivery is trending, with a focus on designing multifunctional nanoparticles that enhance targeting and therapeutic efficacy. - Biologics and Biosimilars:
Research on biologics and biosimilars is on the rise, with an emphasis on their formulation, stability, and delivery methods to improve patient outcomes. - Personalized and Precision Medicine:
The trend towards personalized medicine is emerging, focusing on tailoring drug therapies based on individual patient characteristics and disease profiles. - Sustainable and Green Chemistry Approaches:
Research emphasizing sustainable practices in drug formulation and delivery, including the use of biodegradable materials and eco-friendly manufacturing processes, is gaining popularity. - Real-Time Monitoring and Smart Drug Delivery Systems:
Emerging technologies for real-time monitoring of drug delivery systems and adaptive drug release mechanisms are becoming increasingly important in the field.
Declining or Waning
- Traditional Pharmaceutical Formulations:
Research focused on conventional oral dosage forms, such as tablets and capsules, has decreased, as the field shifts towards more innovative delivery systems and formulations. - In Vivo Animal Studies:
There appears to be a reduction in studies primarily relying on animal models for pharmacokinetic evaluations, as researchers increasingly seek alternative methods that align with ethical standards and regulatory changes. - Small Molecule Drug Development:
The focus on traditional small molecule drug development has waned, with a noticeable shift toward biologics and complex formulations that leverage advanced nanotechnologies. - Non-targeted Drug Delivery Systems:
Research on non-targeted or less sophisticated drug delivery systems is declining, overshadowed by advancements in targeted and personalized medicine approaches.
Similar Journals
Pharmaceuticals
Transforming Ideas into Breakthroughs in Drug DevelopmentPh pharmaceuticals is a leading peer-reviewed journal published by MDPI, focused on the dynamic fields of pharmaceutical science, drug discovery, and molecular medicine. Since its inception, the journal has established itself as a vital resource for researchers and practitioners, boasting an impressive impact factor reflected in its Q1 and Q2 quartile rankings across multiple categories, including Pharmaceutical Science and Drug Discovery. As an open access journal since 2009, Pharmaceuticals promotes the dissemination of cutting-edge research and innovative findings globally, facilitating collaboration and knowledge sharing among scientists. With a robust ranking in Scopus, specifically at Rank #56 in Pharmaceutical Science and Rank #65 in Drug Discovery, the journal serves as a critical platform for advancing the field and supporting future developments in therapeutics and pharmaceuticals. Based in Switzerland, Pharmaceuticals continues to inspire a diverse readership of scholars and healthcare professionals who are dedicated to improving health outcomes through innovative research.
Iranian Journal of Pharmaceutical Research
Advancing pharmaceutical knowledge for a healthier tomorrow.Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.
CURRENT MEDICINAL CHEMISTRY
Shaping Tomorrow’s Medicines Through Rigorous Research.Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Innovating drug delivery for a healthier tomorrow.European Journal of Pharmaceutics and Biopharmaceutics is a leading academic journal published by Elsevier, dedicated to advancing the field of pharmaceutical sciences through high-quality research. Established in 1991, this multidisciplinary journal offers a platform for the dissemination of innovative findings in pharmaceutics and biopharmaceutics, covering crucial aspects such as drug formulation, delivery systems, and the interface of pharmaceutical formulation with biological systems. The journal is well-regarded for its impact, earning a Q1 status in Pharmaceutical Science and consistent Q2 rankings in both Biotechnology and Medicine (Miscellaneous) categories in 2023, thereby highlighting its significance in the scientific community. With an impressive Scopus ranking of 26th percentile in Pharmaceutical Science and 60th percentile in Biotechnology, it positions itself firmly at the forefront of research, supporting researchers, professionals, and students in their quest to address complex health challenges. While the journal does not offer an open-access option, it facilitates a rigorous peer-review process, ensuring that published articles meet the highest standards of scientific integrity. For those looking to make meaningful contributions to the field, the European Journal of Pharmaceutics and Biopharmaceutics serves as an essential resource and reference point.
RSC Medicinal Chemistry
Catalyzing Change in Drug Discovery and DevelopmentRSC Medicinal Chemistry is a pivotal journal in the realm of medicinal chemistry, published by the esteemed Royal Society of Chemistry. With a focus on innovative research that intersects various disciplines such as biochemistry, drug discovery, pharmaceutical science, and organic chemistry, this journal serves as a vital resource for researchers, professionals, and students alike. Its impressive impact factor and notable rankings—positioning it within the Q1 and Q2 quartiles across critical categories—underscore its significance in advancing knowledge and fostering collaboration within the scientific community. RSC Medicinal Chemistry is dedicated to open access, ensuring that cutting-edge findings on drug design and therapeutic applications are freely available to enhance global research efforts. With a commitment to publication excellence from 2020 to 2024, it is a prominent platform where groundbreaking ideas meet practical implications, making it indispensable for anyone committed to the forefront of medicinal advances.
ADVANCED DRUG DELIVERY REVIEWS
Unveiling the Future of Drug Delivery.ADVANCED DRUG DELIVERY REVIEWS, published by ELSEVIER, is a leading journal in the field of pharmaceutical sciences, particularly acclaimed for its contributions to the disciplines of pharmacology, toxicology, and pharmaceutics. With an impressive 2023 Scopus rank of #1 out of 183 in its category, this journal is situated in the Q1 quartile, reflecting its high impact and the relevance of its published research. Since its inception in 1987, it has continually focused on the latest advancements in drug delivery systems, making it an indispensable resource for researchers, professionals, and students interested in the innovative developments that shape the pharmaceutical landscape. The journal aims to publish comprehensive and authoritative reviews that foster a deeper understanding of drug delivery mechanisms, technologies, and their clinical applications. Although it operates under a subscription model, the value it provides through rigorous peer-reviewed content ensures it remains an essential tool for anyone seeking to enhance their knowledge in this rapidly evolving field.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Elevating Drug Delivery: Where Science Meets TechnologyThe Journal of Drug Delivery Science and Technology, published by Elsevier, stands at the forefront of pharmaceutical research, focusing on innovative drug delivery systems and technologies. With a robust impact factor reflected in its Q1 rating within the pharmaceutical sciences category, this journal is recognized for its high-quality contributions, ranking #30 out of 183 in the Scopus pharmacology and toxicology category (2023). Since its inception in 2004, the journal has been pivotal in disseminating groundbreaking research and advancements in drug formulation and delivery methodologies. Researchers and practitioners alike benefit from its comprehensive articles, which are accessible under open access options, ensuring widespread dissemination of knowledge. As it converges towards its 20th anniversary in 2024, the journal continues to enhance its impact on the scientific community, paving the way for future innovations in drug delivery.
Pharmaceutical Sciences
Exploring innovative solutions in pharmaceutical sciences.Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.
Turkish Journal of Pharmaceutical Sciences
Exploring the Frontiers of Molecular MedicineThe Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
Elevating Pharmaceutical Research to New Heights.PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY is a premier journal published by Taylor & Francis Ltd that focuses on the latest advancements and innovations in the field of pharmaceutical science. Established in 1996, this journal has evolved to encompass a wide array of interdisciplinary studies relevant to drug development, formulation technology, and delivery systems, serving as a platform for researchers and professionals to share groundbreaking findings. With an impressive impact factor and ranked in both Q2 in Pharmaceutical Science and Q3 in Medicine (miscellaneous), it positions itself among the top-tier journals in pharmacology and toxicology. The journal's insights are critical for scholars and practitioners aiming to enhance therapeutic efficacy and safety. Access options for the content remain traditional, thus supporting a comprehensive approach to scientific literature. Throughout its converged years up to 2024, PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY continues to play a vital role in shaping pharmaceutical education and practice.